secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2023-02-21T23:59:59+00:00
Accession:  0001493152-23-005702
Event type: debt
Sentiment:  neutral
Materiality: 0.50
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $111,111 convertible note to ONE44 Capital LLC
-----------------------------------------------------------------------

- Principal $111,111; net proceeds $100,000 after $11,111 original issue discount.
- Interest 10% per annum, payable in common stock; maturity Feb 14, 2024.
- Conversion price at 60% of lowest trading price over prior 10 days (50% if DTC chill).
- Prepayment allowed within 180 days with premiums of 120%-135% of face amount.
- Proceeds used for general working capital; note issued under Section 4(a)(2) exemption.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223005702/0001493152-23-005702-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315223005702/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-005702

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer